Biomedical Technologies Enhances Lipoprotein Manufacturing Capabilities
News Jun 01, 2015
Preparative ultracentrifuges are used in biology for gradient separations, where the molecules in a sample are separated using a substance of graduated density, such as salt gradients for proteins. The process is often gradual and involves many sequential steps to obtain the desired gradient. BT is now able to double its lipoprotein manufacturing capability and significantly reduce lead times for both standard and custom products.
The lipoprotein manufacturing process is now 24 hours a day, 7 days a week to meet customers' demands.
Kristy McGuire, Laboratory Manager, commented: 'We are committed to our customers and believe that investing in the second ultracentrifuge will enhance our manufacturing capabilities and reduce the lead time on custom products, ultimately resulting in our customers receiving a first class service that exceeds their expectations.
Worms Exhibit Fear and Respond to Anti-anxiety MedsNews
A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE